Research Highlight | Published:

DIABETES

Teplizumab delays onset of type 1 diabetes mellitus

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

    Original article

    1. Herold, K. C. et al. An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa1902226 (2019)

    Download references

    Author information

    Correspondence to Alan Morris.

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark